Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing?

Multiple Sclerosis and Related Disorders(2022)

Cited 3|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined